Ajay Agarwal

Ajay Agarwal

Active Director Director DIN 06876995
DIN 06876995 First appointment Jun 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2014
Shareholding value •••• Premium profile

About Ajay Agarwal

Data last updated:

Ajay Agarwal is a Director at Aushadh Biotech Private Limited (since 2014). The company operates in Pharma. Aushadh Biotech Private Limited reported revenue of ₹37.4 Lakh (FY 2022).

DIN 06876995
Primary Designation Director
Industry Pharma
First Appointment 05 Jun 2014
Oldest Company Age 12 yrs
Largest company Aushadh Biotech Private Limited · ₹37.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aushadh Biotech Private Limited U24100UP2014PTC064189
Director05 Jun 20142014₹37.4 Lakh (FY 2022)Active

Board colleagues of Ajay Agarwal

Directorship timeline

Open interactive timeline →
Aushadh Biotech Private Limited
Premium access

Shareholding and investment profile for Ajay Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Agarwal

Ajay Agarwal currently holds 1 directorship: Aushadh Biotech Private Limited (Director, since 05 Jun 2014, revenue ₹37.4 Lakh (FY 2022)).

Ajay Agarwal was first appointed on 05 Jun 2014 as Director at Aushadh Biotech Private Limited.

The current boards of Ajay Agarwal's companies include Anuradha Agarwal (Aushadh Biotech Private Limited), Aviral Agarwal (Aushadh Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available